Onco-Innovations pioneers cancer research, developing cutting-edge therapies to prevent and treat cancer. With exclusive global rights to groundbreaking technology targeting solid tumors, the company aims to set new targets in oncology, improving patient outcomes and offering hope. Through the acquisition of Inka Health and its SynoGraph AI platform, they enhance precision oncology by accelerating patient identification, optimizing treatment planning, and streamlining drug development across their pipeline. Based in Calgary, Alberta, Canada, Onco-Innovations operates globally in oncology R&D and biotech investment activity.
No recent news for this company.
No recent deals for this company.